Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C13H9N2O4.Cu |
| Molecular Weight | 577.989 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu++].COC1=CC=CC2=[N+]([O-])C3=C([O-])C=CC=C3[N+]([O-])=C12.COC4=C5C(=CC=C4)[N+]([O-])=C6C([O-])=CC=CC6=[N+]5[O-]
InChI
InChIKey=WMZHLGPNUXTHSP-UHFFFAOYSA-L
InChI=1S/2C13H10N2O4.Cu/c2*1-19-11-7-3-5-9-13(11)15(18)8-4-2-6-10(16)12(8)14(9)17;/h2*2-7,16H,1H3;/q;;+2/p-2
Cuprimyxin is a topical antibiotic with considerable antibacterial, anti-yeast, and antifungal activity in veterinary applications without the irritation side effects. Cuprimyxin was formulated in cream and tested in vitro against Gram-positive and Gram-negative bacterial and fungal pathogens and yeast infections, in vivo as a cream for otic and ophthalmic infections, and as a suspension with hydrocortisone acetate for the treatment of otitis. The apparent biological mechanism of action involves alteration of the invading bacterial DNA template
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Q728680892
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
39238-36-3
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
ALTERNATIVE | |||
|
C000506
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
SUB06833MIG
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
100000083744
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
3515
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
C80851
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
28069-65-0
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
DTXSID501043412
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
136768
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
m7695
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | Merck Index |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD